Lysogene Aktie
Personal
2020 | 2021 | |
---|---|---|
Personal am Ende des Jahres | 23 | 23 |
Umsatz pro Mitarbeiter in Mio. EUR | 0,58 | 0,16 |
Bilanz (in Mio. EUR) - Aktiva
2020 | 2021 | |
---|---|---|
Summe Umlaufvermögen | 26 | 18 |
Summe Anlagevermögen | 9 | 6 |
Summe Aktiva | 28 | 20 |
Bilanz (in Mio. EUR) - Passiva
2020 | 2021 | |
---|---|---|
Gesamtverschuldung/ -verbindlichkeiten | 2 | 10 |
Summe Fremdkapital | 22 | 24 |
Summe Eigenkapital | 7 | -4 |
Summe Passiva | 28 | 20 |
Management
Carole Deffez
Independent Non-Executive Director |
Céline Fantin
Independent Non-Executive Director |
Côme de La Tour du Pin
Chief Financial Officer |
Karen Pignet-Aiach
Chairman & Chief Executive Officer |
Marie Deneux
Chief Regulatory Officer |
Marie Trad
Chief Medical Officer |
Michel Picot
Independent Non-Executive Director |
Peter Lichtlen
Independent Non-Executive Director |
Ralph Laufer
Chief Scientific Officer |